These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20943783)

  • 1. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
    Peacock M; Bilezikian JP; Bolognese MA; Borofsky M; Scumpia S; Sterling LR; Cheng S; Shoback D
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E9-18. PubMed ID: 20943783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study.
    Peacock M; Bolognese MA; Borofsky M; Scumpia S; Sterling LR; Cheng S; Shoback D
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4860-7. PubMed ID: 19837909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery.
    Khan A; Bilezikian J; Bone H; Gurevich A; Lakatos P; Misiorowski W; Rozhinskaya L; Trotman ML; Tóth M
    Eur J Endocrinol; 2015 May; 172(5):527-35. PubMed ID: 25637076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling.
    Cetani F; Saponaro F; Banti C; Cianferotti L; Vignali E; Chiavistelli S; Viccica G; Pinchera A; Marcocci C
    J Endocrinol Invest; 2012 Jul; 35(7):655-60. PubMed ID: 21971564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low-dose cinacalcet reduces serum calcium in patients with primary hyperparathyroidism not eligible for surgery].
    Arranz Martín A; Azcárate Villalón A; Luque Ramírez M; Santana Durán B; Marazuela Azpíroz M; Paniagua Ruiz A; Carraro R; Gómez Pan A
    Endocrinol Nutr; 2011 Jan; 58(1):24-31. PubMed ID: 21277266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism.
    Faggiano A; Di Somma C; Ramundo V; Severino R; Vuolo L; Coppola A; Panico F; Savastano S; Lombardi G; Colao A; Gasperi M
    Endocrine; 2011 Jun; 39(3):283-7. PubMed ID: 21445714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the use of cinacalcet in the management of primary hyperparathyroidism.
    Marcocci C; Cetani F
    J Endocrinol Invest; 2012 Jan; 35(1):90-5. PubMed ID: 22104762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCl.
    Henrich LM; Rogol AD; D'Amour P; Levine MA; Hanks JB; Bruns DE
    Clin Chem; 2006 Dec; 52(12):2286-93. PubMed ID: 17105782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.
    Marcocci C; Chanson P; Shoback D; Bilezikian J; Fernandez-Cruz L; Orgiazzi J; Henzen C; Cheng S; Sterling LR; Lu J; Peacock M
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2766-72. PubMed ID: 19470620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism.
    Ogrin C
    Minerva Endocrinol; 2013 Sep; 38(3):337-8. PubMed ID: 24126554
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
    Takeuchi Y; Takahashi S; Miura D; Katagiri M; Nakashima N; Ohishi H; Shimazaki R; Tominaga Y
    J Bone Miner Metab; 2017 Nov; 35(6):616-622. PubMed ID: 27873072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.
    Leca N; Laftavi M; Gundroo A; Kohli R; Min I; Karam J; Sridhar N; Blessios G; Venuto R; Pankewycz O
    Am J Transplant; 2006 Oct; 6(10):2391-5. PubMed ID: 16869807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
    Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
    Silverberg SJ; Rubin MR; Faiman C; Peacock M; Shoback DM; Smallridge RC; Schwanauer LE; Olson KA; Klassen P; Bilezikian JP
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3803-8. PubMed ID: 17666472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinacalcet for the treatment of primary hyperparathyroidism.
    Dillon ML; Frazee LA
    Am J Ther; 2011 Jul; 18(4):313-22. PubMed ID: 20228675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinacalcet for hyperparathyroidism in pregnancy and puerperium.
    Horjus C; Groot I; Telting D; van Setten P; van Sorge A; Kovacs CS; Hermus A; de Boer H
    J Pediatr Endocrinol Metab; 2009 Aug; 22(8):741-9. PubMed ID: 19845125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and one-year effects of cinacalcet in patients with persistent primary hyperparathyroidism after unsuccessful parathyroidectomy.
    Iglesias P; Ais G; González A; Tajada P; García Arévalo C; Fernández Pardo E; Díez JJ
    Am J Med Sci; 2008 Feb; 335(2):111-4. PubMed ID: 18277118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery.
    Misiorowski W; Zgliczyński W
    Endokrynol Pol; 2017; 68(3):306-310. PubMed ID: 28660989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism.
    Timmons JG; Manners R; Bailey M; McDougall C
    Hormones (Athens); 2021 Sep; 20(3):587-589. PubMed ID: 33881757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.